Rare diseases
Investigational molecules
Locations
379 conditions with trials, the busiest first
1 276 trials across Europe, recruiting first
Study on the Effects of Lunsekimig (SAR443765) in Adults with High-Risk Asthma Not Eligible for Biologic Treatment
BelgiumStudy on the Effects of Itepekimab for Patients with Chronic Rhinosinusitis Without Nasal Polyps
BelgiumStudy on the Effectiveness and Safety of Camlipixant for Adults with Refractory or Unexplained Chronic Cough
CzechiaStudy of Durvalumab and Chemotherapy for Patients with Resectable Non-Small Cell Lung Cancer
AustriaStudy Comparing Ivonescimab with Chemotherapy to Pembrolizumab with Chemotherapy for Patients with Metastatic Squamous Non-Small Cell Lung Cancer
BelgiumStudy on the Effects of SAR443765 and Mometasone Furoate in Adults with Chronic Rhinosinusitis with Nasal Polyps
BelgiumStudy on the Effectiveness and Safety of Tanimilast for Patients with Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis
AustriaStudy on the Effectiveness and Safety of CHF6001 DPI with Roflumilast for Patients with Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis
AustriaStudy of Rocatinlimab compared to Placebo to help adults with Moderate to Severe Asthma
BulgariaStudy on the Effects of Camlipixant in Adults with Refractory or Unexplained Chronic Cough
BelgiumStudy of dupilumab added to inhaled corticosteroids and long-acting beta-agonists compared to high-dose inhaled therapy in adolescents and adults with uncontrolled asthma
DenmarkStudy on the Effectiveness and Safety of Budesonide, Glycopyrronium, and Formoterol Inhaler for Adults and Adolescents with Severe Asthma Not Well Controlled
BulgariaThe therapies tested most often in Respiratory, thoracic and mediastinal disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
